FFAR4

  • 2 independent labs in 2 countries
  • Funders: National Natural Science Foundation of China and 1 more
  • Human trial1
  • Animals2

Interventions

2

Alpha-linolenic acid

upin mice1

1 study
  1. Alpha-linolenic acid activates FFAR4 in mice.

    “allosterically modulate and synergistically activate GPR120 for macrophagic phagocytosis and clearance of β-amyloid aggregates in Alzheimer's disease mice”

    Animalsin Alzheimer's disease mice

    Allosteric activation of a cell-type-specific GPR120 inhibits amyloid pathology of Alzheimer's disease

    Nature aging19 Dec 2025

More on Alpha-linolenic acid

Eicosapentaenoic acid + docosahexaenoic acid

upin humans1

1 study
  1. Eicosapentaenoic acid + docosahexaenoic acid activates FFAR4 in humans.

    “Supplementation with EPA and DHA enhanced FFAR4 activation at the end of the intervention.”

    Human trialin obese individuals on progressive calorie restrictionPBMC8 weeksn = 55

    Marine ω-3 PUFA Supplementation Enhances FFAR4 Activation and Reduces Inflammatory Markers in PBMC of Subjects with Obesity: A Randomized Controlled Trial (EPICO)

    Nutrients21 Nov 2025

More on Eicosapentaenoic acid + docosahexaenoic acid

Effects

2

Amyloid pathology

is required forin mice1

1 study
  1. FFAR4 is required for amyloid pathology in mice.

    “A cell-type-specific deletion of GPR120, or Gαi1, completely abrogates the therapeutic effects of ALA and EDA.”

    Animalsfor therapeutic effects of ALA and EDA

    Allosteric activation of a cell-type-specific GPR120 inhibits amyloid pathology of Alzheimer's disease

    Nature aging19 Dec 2025

Lung damage

downin mice1

1 study
  1. FFAR4 decreases lung damage in mice.

    “FFAR4 overexpression through intratracheal injection of adeno-associated virus and the administration of the FFAR4 agonist TUG891 showed therapeutic effects on CS-induced lung damage”

    Animalscigarette smoke exposurelung

    Phytosphingosine Alleviates Cigarette Smoke-Induced Bronchial Epithelial Cell Senescence in Chronic Obstructive Pulmonary Disease by Targeting the Free Fatty Acid Receptor 4

    MedComm29 Aug 2025

Latest

Nov 2025: 1Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 02 in 12 months